Company Profile

Cash Flow

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco

BSE841.8528.3 (+3.48 %)

PREV CLOSE ( ) 813.55

OPEN PRICE ( ) 841.05

BID PRICE (QTY) 840.75 (4)

OFFER PRICE (QTY) 841.60 (64)

VOLUME 207100

TODAY'S LOW / HIGH ( )838.10 862.65

52 WK LOW / HIGH ( )660.05 1504

NSE844.0030.45 (+3.74 %)

PREV CLOSE( ) 813.55

OPEN PRICE ( ) 845.00

BID PRICE (QTY) 843.60 (200)

OFFER PRICE (QTY) 844.00 (8)

VOLUME 2650398

TODAY'S LOW / HIGH( ) 838.40 864.80

52 WK LOW / HIGH ( )726.8 1505

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

22914.00

16735.00

8619.00

2022.00

5796.00

Adjustment

-223.00

1338.00

1020.00

1239.00

621.00

Changes In working Capital

-1997.00

-3094.00

627.00

-2314.00

-2129.00

Cash Flow after changes in Working Capital

20694.00

14979.00

10266.00

947.00

4288.00

Cash Flow from Operating Activities

16968.00

12116.00

8491.00

465.00

2988.00

Cash Flow from Investing Activities

-14145.00

-10327.00

-4771.00

-53.00

-1033.00

Cash Flow from Financing Activities

-2107.00

-2469.00

-3630.00

348.00

-1857.00

Net Cash Inflow / Outflow

716.00

-680.00

90.00

760.00

98.00

Opening Cash & Cash Equivalents

704.00

1319.00

1111.00

258.00

198.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-220.00

65.00

118.00

93.00

-38.00

Closing Cash & Cash Equivalent

1200.00

704.00

1319.00

1111.00

258.00